Forward Citations = 19

Loading Chart...

4 inventors (with patents filed for the assignee):

Gary M Onik (6 out of 21 patents)

James A Miessau (5 out of 6 patents)

David G Bostwick (1 out of 1 patent)

4. Dg Bostwick (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12295640 - Cancer immunotherapy by radiofrequency electrical membrane breakdown (RF-EMB) (2025-05-13),

2. 11696797 - Cancer immunotherapy by radiofrequency electrical membrane breakdown (RF-EMB) (2023-07-11),

3. 11612426 - Immunologic treatment of cancer (2023-03-28),

4. 11497544 - Immunologic treatment of cancer (2022-11-15),

5. 11141216 - Radio-frequency electrical membrane breakdown for the treatment of high risk and recurrent prostate cancer, unresectable pancreatic cancer, tumors of the breast, melanoma or other skin malignancies, sarcoma, soft tissue tumors, ductal carcinoma, neoplasia, and intra and extra luminal abnormal tissue (2021-10-12),

6. 10849678 - Cancer immunotherapy by radiofrequency electrical membrane breakdown (RF-EMB) (2020-12-01),

Company Overview

Immunsys, Inc. is a biotechnology company that specializes in developing innovative immunotherapy solutions for various medical conditions. With a team of experienced researchers and scientists, Immunsys is dedicated to revolutionizing the field of immunotherapy through cutting-edge technology and groundbreaking research. Their mission is to improve patient outcomes and quality of life through the development of novel treatments that harness the power of the immune system.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#66 in Fort Lauderdale, FL

#1,451 in Florida

#45,007 in US

Fort Lauderdale, FL, United States of America

Immunsys, Inc.

Forward Citations = 19

4 inventors:

Gary M Onik (6 out of 21 patents)

James A Miessau (5 out of 6 patents)

David G Bostwick (1 out of 1 patent)

4. Dg Bostwick (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Immunsys, Inc.. Retrieved from https://idiyas.com/company/immunsys

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]